These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31492646)

  • 1. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry.
    Hatziagorou E; Orenti A; Drevinek P; Kashirskaya N; Mei-Zahav M; De Boeck K; ;
    J Cyst Fibros; 2020 May; 19(3):376-383. PubMed ID: 31492646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.
    Salsgiver EL; Fink AK; Knapp EA; LiPuma JJ; Olivier KN; Marshall BC; Saiman L
    Chest; 2016 Feb; 149(2):390-400. PubMed ID: 26203598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
    Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients.
    Spicuzza L; Sciuto C; Vitaliti G; Di Dio G; Leonardi S; La Rosa M
    Eur J Clin Microbiol Infect Dis; 2009 Feb; 28(2):191-5. PubMed ID: 18758832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF).
    Viviani L; Harrison MJ; Zolin A; Haworth CS; Floto RA
    J Cyst Fibros; 2016 Sep; 15(5):619-23. PubMed ID: 27050794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
    Ramsay KA; Sandhu H; Geake JB; Ballard E; O'Rourke P; Wainwright CE; Reid DW; Kidd TJ; Bell SC
    J Cyst Fibros; 2017 Jan; 16(1):70-77. PubMed ID: 27515017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of non-tuberculous mycobacteria in children with cystic fibrosis using induced sputum at annual review.
    Ahmed MI; Kulkarni H; Shajpal S; Patel D; Patel P; Claydon A; Modha DE; Gaillard EA
    Pediatr Pulmonol; 2019 Mar; 54(3):257-263. PubMed ID: 30561865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
    Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
    Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Italian Cystic Fibrosis Registry. Report 2011-2014].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
    Low D; Wilson DA; Flume PA
    J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.
    da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA
    BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.
    Arvind B; Medigeshi GR; Kapil A; Xess I; Singh U; Lodha R; Kabra SK
    Indian J Med Res; 2020 Jan; 151(1):65-70. PubMed ID: 32134016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
    Saiman L; Siegel J;
    Am J Infect Control; 2003 May; 31(3 Suppl):S1-62. PubMed ID: 12762292
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ANTIBIOTICS SENSITIVITY OF STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA AND BACTERIA OF BURKHOLDERIA CEPACIA COMPLEX, PERSISTING IN LUNGS OF PATIENTS WITH MUCOVISCIDOSIS (MV)].
    Avetisyan LR; Chernukha MY; Shaginyan IA; Kapranov NI; Siyanova EA; Medvedeva OS; Kondratieva EI; Alekseeva GV; Krasovsky SA; Usacheva MV; Amelina EL
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):3-10. PubMed ID: 26950982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex.
    Dryahina K; Sovová K; Nemec A; Španěl P
    J Breath Res; 2016 Aug; 10(3):037102. PubMed ID: 27506232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
    Govan JR; Brown AR; Jones AM
    Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.